Other news to note for March 31, 2020

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Akers, Aldeyra, Algernon, Alphamab, Altimmune, Aptorum, Arcturus, Atyr, Beigene, Bellerophon, Benitec, Bioduro, Biogen, Biomérieux, Biosig, BMS, Cansino, Cerecor, Clover, Cobra, Covar, Cytodyn, Dynavax, Eisai, Eli Lilly, Gigagen, Gilead, Grifols, GSK, I-Mab, Imbio, Immuron, IMV, Innoplexus, Inovio, J&J, Kissei, Mabpharm, Mateon, Merck, Novartis, Noveome, Numab, Olix, Ono, Pfizer, Premas, Redhill, Resverlogix, Rising, Sanofi, Sanofi Pasteur, Simcere, Sorrento, Translate Bio, Vaxil, Vero, Vir, Vyripharm, Windtree, Wuxi.

Financings for March 31, 2020

Biopharmas in Asia-Pacific raising money in public or private financings, including: Hoth, Karolinska, Onethree, Svenska Vaccinfabriken Produktion.

Appointments and advancements for March 31, 2020

New hires and promotions in the biopharma industry in Asia-Pacific, including: I-Mab Biopharma, Sosei Group.

Regulatory front for March 31, 2020

The latest global regulatory news, changes and updates affecting biopharma, including: Association for Accessible Medicines, Department of Justice, EMA, FDA, Federal Trade Commission, International Coalition of Medicines Regulatory Authorities, SEC, White House, World Health Organization.

Clinical data for March 24-30, 2020

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Altasciences, Cytodyn, Eagle, Healios, Immutep, Medimetriks, Opthea, Otsuka, Partner, Pluristem, Qurient, Regeneron, Revive, Roivant Sciences, Sanofi, Symbio.

Regulatory actions for March 24-30, 2020

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Algernon, Astrazeneca, Beyondspring, Cstone, Daiichi Sankyo, Eisai, EMD Serono, Exelixis, Gilead Sciences, Humanigen, I-Mab, Junshi, Lupin, Mylan, Neurorx, Relief, Samsung Bioepis, Shenzhen Chipscreen Biosciences, Sumitomo Dainippon, Takeda.

No Comments